1. Introduction
===============

The genus *Sinularia* is the most widely distributed soft coral, consisting of almost 90 species, of which more than 50 have been chemically examined \[[@B1-marinedrugs-11-04741],[@B2-marinedrugs-11-04741],[@B3-marinedrugs-11-04741],[@B4-marinedrugs-11-04741],[@B5-marinedrugs-11-04741]\]. Up to now, *Sinularia* has yielded many metabolites, including sesquiterpenes, diterpenes, alkaloids, and polyhydroxylated steroids \[[@B6-marinedrugs-11-04741],[@B7-marinedrugs-11-04741],[@B8-marinedrugs-11-04741],[@B9-marinedrugs-11-04741],[@B10-marinedrugs-11-04741],[@B11-marinedrugs-11-04741],[@B12-marinedrugs-11-04741]\]. These metabolites display a wide range of biological activities, such as antimicrobial, anti-inflammatory, and cytotoxic activities \[[@B13-marinedrugs-11-04741],[@B14-marinedrugs-11-04741],[@B15-marinedrugs-11-04741],[@B16-marinedrugs-11-04741],[@B17-marinedrugs-11-04741],[@B18-marinedrugs-11-04741]\]. In our endeavor to explore the bioactive secondary metabolites from marine invertebrates, sinularianins A (**1**) and B (**2**) were reisolated along with four new sesquiterpenes, sinularianins C--F (**3**--**6**) from soft coral *Sinularia* sp., collected at Dongluo Island, Hainan province, China, at a depth of 10 m. Sinularianin A and B have been isolated from the Formosan coral *Sinularia* sp., but their anti-inflammatory activation were tested for the first time. Similar sesquiterpenes had been isolated mostly from the plant *Valeriana officinalis*, which was used as an anti-inflammatory remedy in Europe, and were active as inhibitors of NF-κB \[[@B19-marinedrugs-11-04741]\]. In this paper, we describe the isolation, structure elucidation, and the NF-κB inhibitory potential of these compounds.

2. Results and Discussion
=========================

The soft coral *Sinularia* sp. was dissolved in 85% EtOH, and the extract separated by silica gel column chromatography, Sephadex LH-20, and semi-preparative HPLC to obtain new sesquiterpenes, sinularianins C--F (**3**--**6**), and two known compounds (**1**, **2**) ([Figure 1](#marinedrugs-11-04741-f001){ref-type="fig"}).

![Structures of the compounds **1**--**6**.](marinedrugs-11-04741-g001){#marinedrugs-11-04741-f001}

Sinularianins A (**1**) and B (**2**) were previously isolated from the soft coral *Sinularia* sp., collected off the northeastern Taiwan coast, in May 2004, at a depth of 10 m. Sinularianin A (**1**) possesses an unprecedented bicyclic skeleton sinulariolane. Sinularinin B (**2**) was the only example of valerenane-related sesquiterpene with a spiro-butenolide moiety \[[@B10-marinedrugs-11-04741]\]. The valerenane-related sesquiterpenes had been firstly reported from the plant *Valeriana officinalis* \[[@B20-marinedrugs-11-04741],[@B21-marinedrugs-11-04741]\], and several representatives have been reported from a marine alga \[[@B22-marinedrugs-11-04741]\] and a soft coral \[[@B23-marinedrugs-11-04741]\]. Sinularinin A (**1**) and B (**2**), were reisolated and identified by comparison of their ^1^H and ^13^C NMR data with those reported \[[@B10-marinedrugs-11-04741]\].

Sinularianin C (**3**) was isolated as a colorless oil. Its molecular formula was established as C~16~H~22~O~4~ on the basis of the positive HRESIMS at *m*/*z* 301.1416 (Calcd for C~16~H~22~NaO~4~, 301.1416), indicating six degrees of unsaturation ([Supplementary Figure S1](#marinedrugs-11-04741-s001){ref-type="supplementary-material"}). The ^1^H NMR spectrum ([Table 1](#marinedrugs-11-04741-t001){ref-type="table"}) revealed the presence of four singlet methyls (δ~H~ 1.00, 1.41, 1.86, 3.17), three methylene signals (δ~H~ 1.95, 1H, m; 1.53, 1H, m; 1.96, 1H, m; 1.56, 1H, m; 2.26, 1H, d, *J* = 16.0 Hz; 1.76, 1H, dd, *J* = 16.0, 5.0 Hz), three methine signals (2.00, 1H, d, *J* = 13.0 Hz; 2.43, 1H, m; 3.11, 1H, d, *J* = 5.0 Hz), and one olefinic proton (δ~H~ 7.17, 1H, d, *J* = 1.5 Hz) ([Supplementary Figure S2](#marinedrugs-11-04741-s001){ref-type="supplementary-material"}). The ^13^C NMR spectra, together with HSQC, showed 16 signals for four methyls (δ~C~ 10.3, 20.5, 21.3, 50.8), three sp^3^ methylenes (δ~C~ 23.6, 35.7, 38.7), three sp^3^ methines (δ~C~ 41.1, 50.4, 59.5), three sp^3^ oxygenated quaternary carbons (δ~C~ 61.8, 84.2, 86.5), one sp^2^ methine (δ~C~ 154.7), one sp^2^ quaternary carbon (δ~C~ 129.5), and one carbonyl carbon (δ~C~ 175.6) ([Supplementary Figures S3 and S4](#marinedrugs-11-04741-s001){ref-type="supplementary-material"}). Both the ^1^H and ^13^C NMR spectra of **3** showed a close similarity to those of **2** \[[@B10-marinedrugs-11-04741]\]. However, the close comparison of the ^13^C NMR spectroscopic data of **2** and **3** revealed some differences: one trisubstituted double bond in **2** was changed to the epoxy three-menbered ring (δ~C~ 61.8, 59.5) in **3**, and an additional methoxyl (δ~C~ 50.8, δ~H~ 3.17, 3H, s, H-16) was observed in **3**. This assumption was supported by the correlation of H-11 to C-4, C-5, and C-6, H-6 to C-5, and C-7, H-7 to C-5 and C-6 in the HMBC spectrum ([Figure 2](#marinedrugs-11-04741-f002){ref-type="fig"}). Furthermore, the methoxyl substituent was determined to be connected to position C-1 on the basis of the HMBC correlation from 16-OMe to C-1 ([Supplementary Figure S5](#marinedrugs-11-04741-s001){ref-type="supplementary-material"}).
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###### 

^1^H and ^13^CNMR spectroscopic data for compounds **3** (500/125 MHz, in MeOD, δ in ppm, *J* in Hz) and **4** (in CDCl~3~).

  Position   3                     4                       
  ---------- --------------------- ------- --------------- -------
  1                                84.2                    78.4
  2          1.95 m                35.7    1.92 m          43.1
             1.53 m                        1.79 m          
  3          1.96 m                23.6    2.01 m          25.9
             1.56 m                                        
  4          2.43 m                41.1    2.90 m          41.8
  5                                61.8                    137.5
  6          3.11 d (5.0)          59.5    5.26 s          117.2
  7          2.26 d (16.0)         38.7    2.53 m          39.4
             1.76 dd (16.0, 5.0)           1.91 m          
  8                                86.5                    85.6
  9          2.00 d (13.0)         50.4    1.55 d (12.5)   55.5
  10         1.00 s                21.3    1.26 s          28.5
  11         1.41 s                20.5    1.74 s          20.5
  12         7.17 d (1.5)          154.7   7.03 d (1.5)    150.9
  13                               129.5                   129.7
  14                               175.6                   174
  15         1.86 s                10.3    1.94 d (1.5)    10.6
  16         3.17 s                50.8                    

![Selected HMBC correlations (H → C)of compounds **3**, **5**, and **6**.](marinedrugs-11-04741-g002){#marinedrugs-11-04741-f002}

The relative stereochemistry of **3** was established by the detailed analysis of correlations observed in the NOESY spectrum ([Figure 3](#marinedrugs-11-04741-f003){ref-type="fig"}). In the NOESY spectrum, H-9 showed correlation with H-7β (δ~H~ 2.26, d, *J* = 16.0 Hz), which in turn correlated with H-12, suggesting the β orientations of H-9 and H-12. Furthermore, NOE interactions were observed between H~3~-10/H-4, H~3~-11/H-4, H~3~-11/H-6, and H-6/H-7α (δ~H~ 1.76, dd, *J* = 16.0, 5.0 Hz), while both H~3~-10 and H-4 did not show correlations with H-9, suggesting the *α* orientation of H~3~-10, H~3~-11, H-4, and H-6 ([Supplementary Figure S6](#marinedrugs-11-04741-s001){ref-type="supplementary-material"}).

![Selected NOE correlations of compounds **3** and **4**.](marinedrugs-11-04741-g003){#marinedrugs-11-04741-f003}

Sinularianin D (**4**) was isolated as a colorless oil. The ESI-MS showed the \[M + Na\]^+^ ion at *m*/*z*: 271 ([Supplementary Figure S7](#marinedrugs-11-04741-s001){ref-type="supplementary-material"}). Its ^1^H and ^13^C NMR spectroscopic data were also very similar to those of **2** ([Supplementary Figures S8 and S9](#marinedrugs-11-04741-s001){ref-type="supplementary-material"}). However, a close inspection of their ^1^H NMR spectroscopic data revealed some difference: H-4 and H~3~-10 were shifted downfield from 2.57 to 2.90, and from 1.12 to 1.26 respectively, and H-9 was shifted upfield from 1.99 to 1.55. This suggested that the configuration at H-1 and H-4 in **4** should be β orientation compared to α orientation in **2**, which was supported by the NOESY experiment ([Figure 3](#marinedrugs-11-04741-f003){ref-type="fig"}). In the NOESY spectrum, H-9 showed correlation with H~3~-10, H-4, and H-7β, suggesting the β orientations of H-4, H-9, H-7β, and H~3~-10 ([Supplementary Figure S10](#marinedrugs-11-04741-s001){ref-type="supplementary-material"}).

Sinularianin E (**5**) was isolated as a colorless oil, and assigned the molecular formula of C~16~H~24~O~4~ by the positive HRESIMS at *m/z* 303.1563 (Calcd for C~16~H~24~NaO~4~, 303.1572) ([Supplementary Figure S11](#marinedrugs-11-04741-s001){ref-type="supplementary-material"}). The ^1^H and ^13^C NMR spectroscopic data of **5** indicated sixteen carbon signals: four singlet methyls, four methylenes, three olefinic methines, and five quaternary carbons ([Supplementary Figures S12--S14](#marinedrugs-11-04741-s001){ref-type="supplementary-material"}). The ^1^H NMR spectrum showed signals of four olefinic protons (δ~H~ 5.42, 1H, t, *J* = 7.0 Hz; 6.36, 1H, dd, *J* = 17.5, 10.5 Hz; 5.13, 1H, d, *J* = 17.5 Hz; 4.96, 1H, d, *J* = 10.5 Hz), one methoxy group (δ~H~ 3.72), two vinyl methyls (δ~H~ 2.14, s; 1.74, s), and one other methyl (δ~H~ 1.40, s) ([Table 2](#marinedrugs-11-04741-t002){ref-type="table"}). The gross structure of **5** was established by the assistance of extensive 2D NMR analysis ([Figure 2](#marinedrugs-11-04741-f002){ref-type="fig"}). The methoxycarbonyl was confirmed by HMBC correlations from 16-OMe to C-1. The methyl protons resonating at δ~H~ 1.40 and the quaternary carbon resonating at δ~C~ 72.9 indicated that this methyl and a hydroxyl group should be positioned at C-2 by the HMBC correlations from H-15 to C-1, C-2, and C-3 ([Supplementary Figure S15](#marinedrugs-11-04741-s001){ref-type="supplementary-material"}). The olefinic methyls (δ~H~ 2.14, s; 1.74, s) attached at C-6 and C-10 were confirmed by the HMBC correlations from H-14 to C-5, C-6, and C-7 and H-13 to C-9, C-10, and C-11. Furthermore, the HMBC correlations from H-9 to C-8, and C-10, H-12 to C-10, and C-11 established the terminal diene unit. Other key informative HMBC correlations from H-3 to C-2, and C-4, H-5 to C-4, H-8 to C-7, C-9, and C-10, established the planar structure of **5**. The double bond at C-5 was assigned the *Z*-geometry on the basis of the downfield chemical shifts of C-14 (δ~H~ 19.7) \[[@B24-marinedrugs-11-04741]\]. The geometry of the disubstituted double bond (C-9) was determined to be *E* by comparison of the spectral data with those reported in literature \[[@B24-marinedrugs-11-04741]\], whereas the configurations at C-2 remained to be determined. On the basis of above evidences, compound **5** was then identified, and named sinularianin E.
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###### 

^1^H and ^13^C NMR spectroscopic data for compounds **5** and **6** (500/125 MHz, in CDCl~3~, δ in ppm, *J* in Hz).

  Position   5                      6                              
  ---------- ---------------------- ------- ---------------------- -------
  1                                 176.5                          203.2
  2                                 72.9    5.86 s                 131.2
  3          3.15 d (17.5)          52.9                           174.9
             2.80 d (17.5)                                         
  4                                 199.3   4.79 s                 75.3
  5          6.01 s                 122.9   2.65 s                 61.5
  6                                 160.3                          78
  7          2.22 m                 40.9    1.82 m                 34.1
                                            2.12 m                 
  8          2.34 m                 25.8    2.19 m                 22.1
             2.20 m                                                
  9          5.42 t (7.0)           130.8   5.52 m                 132.3
  10                                135                            134.1
  11         6.36 dd (17.5, 10.5)   141     6.36 dd (17.0, 10.5)   141.5
  12         5.13 d (17.5)          111.3   5.10 d (17.0)          110.7
             4.96 d (10.5)                  4.94 d (10.5)          
  13         1.74 s                 11.7    1.76 s                 11.6
  14         2.14 s                 19.7    1.03 s                 22.7
  15         1.40 s                 26.2    3.21 s                 48.5
  16         3.72 s                 52.7    2.16 s                 15.6

Sinularianin F (**6**) was isolated as a colorless oil. It was assigned a molecular formula of C~16~H~24~O~3~ by positive HR-ESI-MS at *m/z* 287.1613 (Calcd for C~16~H~24~NaO~3~, 287.1623) ([Supplementary Figure S16](#marinedrugs-11-04741-s001){ref-type="supplementary-material"}). Analysis of ^1^H and ^13^C NMR data revealed the presence of four methyl groups, three methylene carbons, five methine carbons, and four quaternary carbons ([Supplementary Figures S17--S19](#marinedrugs-11-04741-s001){ref-type="supplementary-material"}). The ^1^H NMR spectrum showed signals of five olefinic protons (δ~H~ 5.86, s; 5.52, m; 6.36, dd, *J* = 17.0, 10.5 Hz; 5.10, d, *J* = 17.0 Hz; 4.94, d, *J* = 10.5 Hz), one oxygenated methane (δ~H~ 4.79, s), one methoxy group (δ~H~ 3.21, s), two vinyl methyls (δ~H~ 1.76, s; 2.16, s), and one other methyl (δ~H~ 1.03, s) ([Table 2](#marinedrugs-11-04741-t002){ref-type="table"}). The HMBC correlations from H-9 to C-8, and C-10, H-12 to C-10, and C-11, H-13 to C-10, and C-11 established the terminal diene unit ([Supplementary Figure S20](#marinedrugs-11-04741-s001){ref-type="supplementary-material"}). The key HMBC correlations of H~3~-16 to C-2, C-3, and C-4 and H-2 to C-1, C-3, C-4, and C-5 indicated the presence of a five-membered carbocycle containing a ketone carbonyl and a trisubstituted double bond ([Figure 2](#marinedrugs-11-04741-f002){ref-type="fig"}), as well as by comparison of the data with that of in agreement with the data of cycloabiesesquine A \[[@B25-marinedrugs-11-04741]\]. The two fragments may be connected *via* the correlations of H-15 to C-5, C-6, and C-7, H-14 to C-6 and H-7 to C-6, C-7, and C-8 in the HMBC spectrum. Two double bonds in the molecule possessed 2*Z* and 9*E* configuration on the basis of the chemical shifts of C-16 and C-13 (δ 15.6 and 11.6, respectively) \[[@B24-marinedrugs-11-04741],[@B25-marinedrugs-11-04741]\].

Although sinularianins E (**5**) and F (**6**) formally displayed a quite different skeleton from that of sinularianins A--D (**1**--**4**), however, they are actually related to each other. From a biosynthetic aspect, sinularinins A--D (**1**--**4**), and F (**6**) could be generated from sinularinin E (**5**), via different reaction cascades as illustrated in the hypothetical biosynthetic pathway ([Scheme 1](#marinedrugs-11-04741-f004){ref-type="scheme"}). As a precursor, sinularianin E (**5**) potentially could be transformed into the key intermediate A by dehydration reaction. Intermediate A could be through different intramolecular Diels Alder cyclization reaction to form sinularianin A (**1**) or valerenolic acid, respectively, and the latter was further modified to produce sinularianin B (**2**). Intermediate A could be also adapted by Michael addition under the H~2~O attack and then immediately lactonized, followed by a DA cyclization to yield sinularianin B (**2**), which after epoxidation and dehydration potentially could be produce epoxide sinularianin C (**3**). Intermediate A might form sinularianin F (**6**) by an aldol condensation.

![Proposed biosynthetic pathway for **1**--**6**.](marinedrugs-11-04741-g004){#marinedrugs-11-04741-f004}

Nuclear factor-κ B (NF-κB) plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory and autoimmune diseases, septic shock, viral infection, and improper immune development \[[@B26-marinedrugs-11-04741]\]. Compounds **1**--**6** were evaluated for inhibition of NF-κB activation using the cell-based HEK293 NF-κB luciferase reporter gene assay. At concentration of 10 µg/mL, sinularianin A and D exhibits a potent effect with inhibitory rates of 41.3%, and 43.0%, respectively. At the same concentration, other compounds showed moderate effects at the same ([Table 3](#marinedrugs-11-04741-t003){ref-type="table"}). The past studies have provided biochemical evidence of valerenane-related sesquiterpenes as anti-inflammatory agents acting via the NF-κB inhibitory potential. The valerenic acid (**3**) reduced NF-κB activity to 25% at concentration of 100 µg/mL \[[@B19-marinedrugs-11-04741]\].
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###### 

Inhibitory rates of NF-κB activation of compounds **1**--**6**.

  Concentration   IR (%)                               
  --------------- -------- ------ ------ ------ ------ ------
  10 µg/mL        41.3     29.6   24.3   43.0   30.0   36.1

3. Experimental Section
=======================

3.1. General Experimental Procedures
------------------------------------

The NMR spectra were recorded on a Bruker AC 500 NMR spectrometer with TMS as an internal standard. IR spectra were recorded on a Nicolet 6700 FT-IR spectrometer. UV spectra were recorded on a Shimadzu UV-2600 UV-Vis spectrophotometer. Optical rotations were measured on a PerKin Elmer 341 polarimeter using a 1 dm path length cell. HR-ESI-MS data were measured on AQUITY UPLC/Q-TOF mass spectrometer. ESI-MS data were measured on Bruker's amaZon SL ion trap LC/MS. Materials for column chromatography were silica gel (100--200, 200--300 mesh, Qingdao Marine Chemical Factory, Qingdao, China), Sephadex LH20 (40--70 µm, Amersham Pharmacia Biotech AB, Uppsala, Sweden), and YMC Gel ODS-A (12 nm, S-50 µm YMC, MA, USA). The silica gel GF~254~ (0.4--0.5 mm) used for TLC were supplied by the Qingdao Marine Chemical Factory, Qingdao, China. HPLC was carried on shimadzu LC-10ATvp with YMC ODS SERIES (YMC-Pack ODS-A, 250 × 10 mm I.D., S-5 µm, 12 nm).

3.2. Animal Material
--------------------

The soft coral *Sinularia* sp. was collected from Dongluo Island, Hainan province of China in July 2009 (7--10 m depth) and identified by Professor Hui Huang, South China Sea Institute of Oceanology, Chinese Academy of Sciences. A voucher specimen (No. 0907010) was deposited in the CAS Key Laboratory of Tropical Marine Bio-resources and Ecology, South China Sea Institute of Oceanology, Chinese Academy of Sciences, Guangzhou, China.

3.3. Extraction and Isolation
-----------------------------

The fresh soft coral (wet, 6 kg) was extracted three times with 95% EtOH (20 L). The extract was concentrated under reduced pressure, and partitioned between H~2~O (4 L) and CHCl~3~ (4 L); the CHCl~3~ layer (120 g) was further partitioned between 85% EtOH (4 L) and petroleum ether (PE; 4 L) to yield 85% EtOH (34 g) and PE (75.6 g) fractions. The 85% EtOH fraction was separated by silica gel column using CHCl~3~/MeOH to yield 11 portions (Frs. s1--s11). Fr. s3 was purified by silica gel column to yield 12 portions, and portion 10 was further purified with semi-preparative HPLC, eluting with MeOH/H~2~O = 65:35 at a flow rate of 2 mL/min, to afford **1** (6.0 mg) and **2** (7.2 mg). Fr. s5 was purified by Sephadex LH-20 using CHCl~3~/MeOH = 1:1 to yield 3 portions, and portion 1 was further purified with semi-preparative HPLC, eluting with MeOH/H~2~O = 57:43 at a flow rate of 2 mL/min, to afford **5** (2.2 mg) and **6** (2.6 mg). Fr. s6 was separated by silica gel column using PE/EtOAc to yield 7 portions, and portion 1 was further purified with semi-preparative HPLC, eluting with MeOH/H~2~O = 70:30 at a flow rate of 2 mL/min, to afford **3** (2.2 mg) and **4** (3.7 mg).

Sinularianin C (**3**): Colorless oil; ^1^H- and ^13^C-NMR (see [Table 1](#marinedrugs-11-04741-t001){ref-type="table"}); HR-ESI-MS *m/z* 301.1416 \[M + Na\]^+^, (Calcd for C~16~H~22~NaO~4~, 301.1416).

Sinularianin D (**4**): Colorless oil; ![](marinedrugs-11-04741-i001.jpg) = −6.0 (*c* = 0.01, MeOH); UV (MeOH): λ~max~ (log ε) = 204.2 (1.70); IR (KBr) ν~max~ 3421, 2927, 2854, 1735, 1666 cm^--1^ ([Supplementary Figure S21](#marinedrugs-11-04741-s001){ref-type="supplementary-material"}); ^1^H- and ^13^C-NMR (see [Table 1](#marinedrugs-11-04741-t001){ref-type="table"}); ESI-MS *m/z* 271 \[M + Na\]^+^, 519 \[2M + Na\]+.

Sinularianin E (**5**): Colorless oil; ^1^H- and ^13^C-NMR (see [Table 2](#marinedrugs-11-04741-t002){ref-type="table"}); HR-ESI-MS *m/z* 303.1563 \[M + Na\]^+^, (Calcd for C~16~H~24~NaO~4~, 303.1572).

Sinularianin F (**6**): Colorless oil; ^1^H- and ^13^C-NMR (see [Table 2](#marinedrugs-11-04741-t002){ref-type="table"}); HR-ESI-MS *m/z* 287.1613 \[M + Na\]^+^, (Calcd for C~16~H~24~NaO~3~, 287.1623).

3.4. The Cell-Based HEK293 NF-κB Luciferase Reporter Gene Assay
---------------------------------------------------------------

All compounds were evaluated for inbibition of NF-κB activation using the cell-based HEK 293 NF-κB luciferase reporter gene assay according to the previously reported procedures \[[@B19-marinedrugs-11-04741]\].

4. Conclusions
==============

The investigation of bioactive natural products from a Hainan soft coral, *Sinularia* sp., has led to the isolation of four new sesquiterpenes, sinularianins C--F (**3**--**6**), along with two other analogues, sinularianins A (**1**) and B (**2**). Compounds **1** and **4** were exhibited a potent inhibitory effect with inhibitory rates of 41.3% and 43.0% at the concentration of 10 µg/mL, respectively. The discovery of new compounds **3**--**6** has added to an extremely diverse and complex array of soft coral sesquiterpenes.
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